To confirm altered PGE2/EP3 signaling as a direct contributor to β-cell dysfunction in this T2D mouse model, we performed ex vivo glucose-stimulated insulin secretion (GSIS) assays with and without the addition of an EP3-selective agonist, sulprostone. Here, INS is linked to type 2 diabetes mellitus.